SMS Pharmaceuticals Ltd

SMS Pharma. | 532815

Live

₹402.70

₹4.36 (-1.07%)

As on 10/07/26, 6:43 PM

Market Cap3,812.11 CR

Current Price₹402.7

High / Low₹447.8 / 207.99

PE Ratio27.27

Book Value₹70.36

Dividend Yield0.19%

ROCE12.53%

ROE11.00%

Face Value₹2.00

Current Vol.3,89,683

Average Vol.---

ISININE812G01025

PB Ratio3.02

Debt to Equity0.5

Net Profit Margin8.07

Operating Margin17.38

Share Price Chart - SMS Pharmaceuticals Ltd

+₹0.00 (+0.00%)6M

Stock Performance

₹407.05₹409

₹402.7

Previous CloseToday's Open

₹207.99₹447.8

₹402.7

52W Low52W High

₹409Today's Open

₹407.05Previous Close

3,89,683Volume

₹207.9952W Low

₹447.852W High

Ratios

No data available

About Company

SMS Pharmaceuticals Limited was incorporated in December, 1987
The company is engaged in the business of manufacturing of Active Pharma Ingredients and their intermediates
Apart from R &D Center at Gagillapur, Hyderabad, the company is having manufacturing facilities at Bachupally, Hyderabad and also at Kandivalasa Village in Vijayanagaram District of Andhra Pradesh
During the year 2015, the company has re-enforced its fundamental strength of FDA compliant facilities by successfully completing the US FDA audits at Kandivalasa and Bachupally facilities
During the year 2015, the company filed 9 Drug Master Files and total DMFs filed up to 31 March 2015 are 24
During the year 2014-15, the Company acquired 12,25,900 equity shares of Rs
VKT Pharma Private Limited
With this the said company has become an associate company
The project of the said associate company is in final stage and at the verge of completion and operations are yet to be commenced
The Company has not having any subsidiaries

Research Calls

Explore all active research calls & maximize your profits

To access, login or signup with ArihantPlus

Technical Indicators

RSI56.43

SMA 20392.55

SMA 50392.07

SMA 100389.09

SMA 200344.77

SMA 10407.21

MACD_12_26_Days8.33

EMA10Day406.15

EMA20Day398.10

EMA50Day391.51

MACD_12_26_9_Days2.91

EMA100Day379.42

EMA200Day351.99

Pivot Points

Volume Analysis

Delivery

Total Volume

Growth Rate

Revenue Growth10.36%

ROE11.46%

EBITDA Margin17.38%

All figures in ₹ Crores

Indicators	2025	2024	2023	2022	2021
Revenue	782.75	709.26	522.05	519.87	563.18
Interest	18.54	23.46	21.91	18.88	11.16
Expenses	643.76	592.64	467.58	405.54	442.07
Financing Profit	145.22	121.08	59.39	119.53	124.56
Financing Margin %	19%	17%	11%	23%	22%
Other Income	6.22	4.46	4.91	5.20	3.45
Depreciation	34.34	31.52	32.13	32.15	22.28
Profit before tax	92.34	66.11	5.35	68.50	91.12
Tax %	27%	26%	27%	1%	33%
Net Profit	67.40	49.20	3.88	67.88	60.96
EPS in Rs	8.16	5.89	-0.83	7.35	7.39

Show % Change

ShareHolding

📊

No Information Available

No shareholding data available at this time.

📊

No Data Available

No Block Deals data available for this company.

News

📊

No Information Available

No news available for this company.

Record Date

Corporate Action

Information

Announcement Day

29 Sept 2025

AGM

09 Aug 2025

22 Sept 2025

Final Dividend (₹0.4)

Recommended the Final Dividend of ~0.40 Paise (Le., 40%) per equity share of face value of ~1/ each for the financial year 2024-25, subject to approval of the members at the ensuing Annual General Meeting (AGM). The AGM date and book closure / record date for the purpose of the payment of dividend will be informed in due course. Fixation of record date for determining the members eligible to receive dividend for the Financial Year 2024-25 (As Per BSE Announcement Dated on: 09/08/2025)

30 May 2025

30 Sept 2024

AGM

05 Aug 2024

23 Sept 2024

Final Dividend (₹0.4)

Recommended the Dividend of Re.0.40 Paise (40%) per equity share of face value of Rs.1/-each for the financial year 2023-24, subject to approval of the members at the ensuing Annual General Meeting (AGM). The AGM date and book closure / record date for the purpose of the payment of dividend will be informed in due course

29 May 2024

06 Mar 2024

EGM

13 Feb 2024

30 Sept 2023

AGM

08 Aug 2023

22 Sept 2023

Final Dividend (₹0.3)

Recommended the Dividend of Re.0.30 Paise (30%) per equity share of face value of Rs.1/-each for the financial year 2022-23.

25 May 2023

30 Sept 2022

AGM

16 Aug 2022

23 Sept 2022

Final Dividend (₹0.3)

Recommended the Dividend of 30% per equity share of face value of Rs. 1/-each for the financial year 2021-22

30 May 2022

30 Sept 2021

AGM

07 Aug 2021

Peers

LTP(₹)	Market Cap(₹ Cr.)	P/E Ratio(Ratio)	P/B Ratio(Ratio)	Cash Earnings(Ratio)	Debt to Equity(Ratio)	Net Profit Ratio(%)
406	3,803	37	5	27	1	8.07%
1,939	4,65,195	37	6	30	0	19.78%
6,811	1,80,823	69	11	59	0	23.41%
4,897	1,65,725	76	20	50	1	11.09%
1,442	1,16,467	31	3	23	0	9.92%
1,160	1,15,695	21	4	17	0	19.86%
2,503	1,14,441	20	5	16	0	14.56%
1,270	1,05,987	26	3	17	0	12.34%
2,531	1,04,544	52	6	36	0	14.39%
1,587	92,144	26	2	17	0	10.98%

Showing 10 of 134 Results

#IndiaInvests

Trusted by 2.5 lac + Indians for their wealth-building needs

Invest in stocks with ease

Open your account in less than 10 mins*

By proceeding, you agree to all T&C *

Top Gainers

Top Losers

DIXONDixon Technologies (India) Ltd
₹13,421-56 (-0.42%)

Frequently Asked Questions

What is Share Price of SMS Pharmaceuticals Ltd?

The current share price of SMS Pharmaceuticals Ltd (SMS Pharma.) is ₹402.70. This price reflects the latest market valuation and is updated in real-time during trading hours.

What is the P/E Ratio of SMS Pharmaceuticals Ltd?

The Price-to-Earnings (P/E) ratio of SMS Pharmaceuticals Ltd is 402.70. This indicates how much investors are willing to pay per rupee of earnings, helping assess if the stock is overvalued or undervalued.

What is the 52-week high and low of SMS Pharmaceuticals Ltd?

SMS Pharmaceuticals Ltd has a 52-week high of ₹447.80 and a 52-week low of ₹207.99. This range shows the stock's price volatility over the past year.

What is the Dividend Yield of SMS Pharmaceuticals Ltd?

SMS Pharmaceuticals Ltd offers a dividend yield of 0.10%. This represents the annual dividend payment as a percentage of the current stock price, indicating the income return for investors.

What is the EPS of SMS Pharmaceuticals Ltd?

The Earnings Per Share (EPS) of SMS Pharmaceuticals Ltd is ₹10.89. EPS indicates the company's profitability on a per-share basis and is a key metric for evaluating financial performance.

What is the ROE of SMS Pharmaceuticals Ltd?

SMS Pharmaceuticals Ltd has a Return on Equity (ROE) of 11.00%. ROE measures how effectively the company uses shareholders' equity to generate profits, with higher values generally indicating better performance.

Disclaimer:

Please note that the above list and information is for research purposes only and are not recommendations. Do your own due diligence or consult an investment advisor before investing. The above data is dynamic in nature and subject to real-time changes and is derived from CMOTS.

Ready to invest smarter?
Download the app today.

GET IT ON

Google Play

4.5

DOWNLOAD ON THE

App Store

4.2

Discover our app's power in seconds. Play Video